· Global Polymerase Chain Reaction (PCR) Devices Market was valued at USD 24.17 billion in 2021 and is expected to reach USD 29.22 billion by 2029, registering a CAGR of 2.40% during the forecast period of 2022-2029. The “consumables” accounts for the largest product type segment in the polymerase chain reaction (PCR) devices market within the forecasted period owing to the substantial demand for testing supplies for the SARS-CoV-2 pandemic. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Get Your Sample Today: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-pcr-devices-market
Market Analysis and Insights
Over recent years, the personalized medicine, which strives to give individual patients with tailored therapies based on the biological basis of disease, has gained immense popularity. A major aspect driving market expansion is the rising desire for personalized and precise treatment. In pharmaceutical and biotechnology research as well as microbiological quality control, the polymerase chain reaction (PCR) method has shown immense growth. These determinants will aid in growth of the polymerase chain reaction (PCR) devices market.
· Global Polymerase Chain Reaction (PCR) Devices Market,
· By Technology (Digital PCR, Real-time PCR),
· Product Type (Instrument, Reagent, Consumables, Others),
· Application (Oncology, Blood Testing, Pathogen Detection, Research, Forensic, Others),
· End-User (Hospital, Diagnostic Center, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Academia, Laboratories) Industry Trends and Forecast to 2029
Buy Now Access Full Report:- https://www.databridgemarketresearch.com/reports/global-pcr-devices-market
Global PCR Devices Market Scope
The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
· Digital PCR
· Real-time PCR
On the basis of technology, the polymerase chain reaction (PCR) devices market is segmented into digital PCR and real-time PCR.
Product Type
· Instrument
· Reagent
· Consumables
· Others
On the basis of product type, the polymerase chain reaction (PCR) devices market is segmented into instrument, reagent, consumables and others. The consumables dominated the market and accounted for the largest revenue share of more than 69.0% owing to the substantial demand for testing supplies for the SARS-CoV-2 pandemic.
Application
· Oncology
· Blood Testing
· Pathogen Detection
· Research
· Forensic
· Others
On the basis of application, the polymerase chain reaction (PCR) devices market is segmented into oncology, blood testing, pathogen detection, research, forensic and others.
End User
· Hospital
· Diagnostic Center
· Pharmaceutical and Biotechnology Companies
· Clinical Research Organizations
· Academia
· Laboratories
On the basis of end-user, the polymerase chain reaction (PCR) devices market is bifurcated into hospital, diagnostic center, pharmaceutical and biotechnology companies, clinical research organizations, academia and laboratories.
Global PCR Devices Market Country Level Analysis
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the rising awareness among patients about early diagnosis of these diseases and increase in the patient pool due to the high prevalence of chronic and infectious diseases within the region.
The countries covered in the polymerase chain reaction (PCR) devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Browse The Table of Contents And List of Figures: https://www.databridgemarketresearch.com/toc/?dbmr=global-pcr-devices-market
Major TOC of the Global PCR Devices Market Report
Chapter One:
MARKET SEGEMENTATION
EXECUTIVE SUMMARY
PREMIUM INSIGHTS
MARKET OVERVIEW
Competitive Landscape and Global PCR Devices Market Share Analysis
Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to polymerase chain reaction (PCR) devices market.
Some of the major players operating in the polymerase chain reaction (PCR) devices market are
· Abbott (U.S.)
· bioMérieux (France)
· BD (U.S.)
· Danaher (U.S.)
· Thermo Fisher Scientific Inc (U.S.)
· Siemens (Germany)
· Agilent Technologies, Inc (U.S.)
· Merck KGaA (Germany)
· Fluidigm (U.S.)
· QIAGEN (Germany)
· Bio-Rad Laboratories, Inc (U.S.)
· Cytiva (U.S.)
· Stryker (U.S.)
· Johnson & Johnson Private Limited (U.S.)
· Smith+Nephew (U.K.)
· Bruker (U.S.)
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best Market opportunities and foster efficient information for your business to thrive in the Market
Contact:
Data Bridge Market Research
Tel: +1-888-3895-2818
Email: Sopan.gedam@databridgeMarket research.com
Browse Related Reports@
Global Bone Anchored Hearing Systems (BAHS) Market
Global Ophthalmic Sutures Market
Global alcohol-dependency treatment market
Global Chronic Obstructive Pulmonary Disease (COPD) Drug Market
